Cargando…
Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study
INTRODUCTION: Patients with ulcerative colitis (UC) are known to have a significantly poor quality of life due to bowel frequency (night) and urgent defecation. Budesonide foam is a topical medication that was approved in Japan in 2017 for the treatment of UC. However, its efficacy in the treatment...
Autores principales: | Miyazaki, Ryosuke, Sakurai, Toshiyuki, Shimada, Mariko, Iwashita, Yuko, Shibuya, Naoki, Akita, Yoshihiro, Miyashita, Haruna, Maruyama, Yuki, Saruta, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233394/ https://www.ncbi.nlm.nih.gov/pubmed/35751039 http://dx.doi.org/10.1186/s12876-022-02388-6 |
Ejemplares similares
-
Correction: Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study
por: Miyazaki, Ryosuke, et al.
Publicado: (2022) -
Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase
por: Sakurai, Toshiyuki, et al.
Publicado: (2022) -
Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
por: Shibuya, Tomoyoshi, et al.
Publicado: (2019) -
Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
por: Sakurai, Toshiyuki, et al.
Publicado: (2023) -
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
por: Kruis, Wolfgang, et al.
Publicado: (2022)